IAIC Information Analysis Inc.

WaveDancer Regains NASDAQ Compliance

WaveDancer Regains NASDAQ Compliance

Professional services company continues listing on the Nasdaq Capital Market

FAIRFAX, Va., Nov. 21, 2023 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (“WaveDancer” or the “Company”) (Nasdaq: WAVD), a professional services company focused on providing technical solutions to the United States Government, today announced that it has received confirmation from The Nasdaq Stock Market (Nasdaq) that WaveDancer has demonstrated compliance with the requirements to remain listed on the Nasdaq Capital Market. Consequently, WaveDancer is now in compliance with all applicable listing standards, and its common stock will continue to be listed on The Nasdaq Capital Market. 

The company had previously been notified that it did not meet the $1 minimum bid price requirement and it was out of compliance with Nasdaq’s minimum stockholders’ equity requirement of $2.5 million. On August 8, 2023, WaveDancer presented its plan to regain compliance by effecting a reverse stock split with the minimum bid price requirements and to ensure that its stockholders’ equity was above the $2.5 million threshold.

On October 18, 2023, WaveDancer effected a one for ten reverse stock split and on October 31, 2023, the Company’s stock traded above $1 for the tenth consecutive trading day, as required. On November 13, 2023, the Company filed its Form 10-Q and reported total stockholders’ equity above $2.5 million. Nasdaq has informed the Company that it will be subject to a Mandatory Panel Monitor for one year. Upon closing of the recently announced merger of WaveDancer and Firefly Neuroscience, Inc. (“Firefly”), expected in Q1 of 2024, ongoing compliance with Nasdaq listing requirements will be based on Firefly.

About WaveDancer

WaveDancer, based in Fairfax, VA, has been servicing federal and commercial customers since 1979. It provides modernization, software development, and cybersecurity services to help organizations meet their business goals through technology.

Additional information for investors

This release may contain forward-looking statements regarding the Company's business, customer prospects, or other factors that may affect future earnings or financial results. Such statements involve risks and uncertainties which could cause actual results to vary materially from those expressed in the forward-looking statements. Investors should read and understand the risk factors detailed in the Company's 10-K for the fiscal year ended December 31, 2022 and in other filings with the Securities and Exchange Commission.

For investor inquiries contact:

Tim Hannon, CFO



EN
21/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Information Analysis Inc.

 PRESS RELEASE

WaveDancer Announces Reverse Stock Split

WaveDancer Announces Reverse Stock Split Common Stock Will Begin Trading on Split-Adjusted Basis on August 13, 2024 FAIRFAX, Va., Aug. 09, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (Nasdaq: WAVD) (“WaveDancer” or the “Company”), announced today that it intends to effect a reverse stock split of its common stock at a ratio of one (1) post-split share for every three (3) pre-split shares. The reverse stock split will become effective at 12:01 p.m., New York time, on Monday, August 12, 2024, and will begin trading on a split-adjusted basis when the market opens on Tuesday, August 13, 2024....

 PRESS RELEASE

Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S...

Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer FAIRFAX, Va. and TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”), a pioneering artificial intelligence (“AI”) company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of Brian M. Posner to its Board of Directors upon closing of its planned merger with WaveDancer, Inc. (“WaveDancer”) (Na...

 PRESS RELEASE

Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Heal...

Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, David Johnson as Executive Chairman, Upon Closing of Its Merger Transaction with WaveDancer FAIRFAX, Va. And TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”), a pioneering artificial intelligence (“AI”) company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of David Johnson as its Executive Chairman upon closing of its planned merger with WaveDance...

 PRESS RELEASE

FireFly Neuroscience Announces Healthcare Science and AI Industry Lead...

FireFly Neuroscience Announces Healthcare Science and AI Industry Leader David DeCaprio to Join Board of Directors Board Appointment is a Key Step Towards Anticipated Trading on NASDAQ FAIRFAX, Va. and TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”), a pioneering AI company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, announces that Healthcare Science and AI Industry leader, David DeCaprio (“DeCaprio”), has entered into an agreement to join the Compan...

 PRESS RELEASE

WaveDancer and Firefly Neuroscience, an AI-Driven Brain Health Company...

WaveDancer and Firefly Neuroscience, an AI-Driven Brain Health Company, Each Receive Respective Stockholder Approvals for Merger Successful votes from both parties’ stockholders mark a critical step toward deal closing with the pioneering artificial intelligence-enabled neurological technology company. FAIRFAX, Va., March 18, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (“WaveDancer”) (Nasdaq: WAVD) and Firefly Neuroscience, Inc. (“Firefly”) an AI-driven brain health company, each received the requisite stockholder approvals required to consummate the merger between both companies. The Wa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch